Sorafenib-asssociated hand-foot syndrome treated with topical calcipotriol
Main Authors: | Serkan Demirkan, MD, Özgür Gündüz, MD, Tuba Devrim, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-07-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512617300802 |
Similar Items
-
Sorafenib induced acral pigmentation: A new entity
by: Mrinal Gupta, et al.
Published: (2015-04-01) -
Sorafenib-induced hand-foot skin reaction
by: Madhvi Trivedi, et al.
Published: (2023-01-01) -
Tumor Hypervascularity and hand-foot-skin reaction predict better outcomes in combination treatment of TACE and Sorafenib for intermediate hepatocellular carcinoma
by: Enxin Wang, et al.
Published: (2019-04-01) -
Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib
by: Koen G. A. M. Hussaarts, et al.
Published: (2020-08-01) -
Complete Response after Short-Term Sorafenib Treatment in a Patient with Lymph Node Metastasis of Hepatocellular Carcinoma
by: Hajime Mizukami, et al.
Published: (2012-07-01)